ArticlePharmaceutical research2016

A Comparative Study of Orally Delivered PBCA and ApoE Coupled BSA Nanoparticles for Brain Targeting of Sumatriptan Succinate in Therapeutic Management of Migraine.

Priti Girotra et al.PubMed ↗Publisher ↗

No numbers read from the abstract.